Scholarlink

<p>The aim of this project was to determine the prevalence of fatty liver among Asian-American patients with chronic hepatitis B in a real-world setting, and to characterize the demographic, body composition and clinical features of these patients. This was a retrospective cross-sectional study of 115 Asian-American CHB patients followed at two clinical liver disease community programs in Southern California. Patients underwent standardized interviews, physical exams, body composition analysis (InBody® scan), laboratory studies, and assessment of liver stiffness and fat by FibroScan®. The median BMI of the cohort was 24.4&#xa0;kg/m<sup>2</sup>, CAP was 250&#xa0;dB/m, and liver stiffness was 5.0&#xa0;kPa. Patients whose BMI were &gt; 23&#xa0;kg/m<sup>2</sup> showed a significant increase in hepatic steatosis, percent body fat, years lived in the US, prevalence and number of metabolic syndrome components (obesity, hypertension, type 2 diabetes mellitus). Asians who immigrate to the US at a younger age have an increased risk of elevated BMI and consequent risk of MASLD. Body composition and liver disease progression differences across BMI in our cohort support the need for population-specific anthropometric parameters and underscores a BMI of 23&#xa0;kg/m<sup>2</sup> as an important cutoff point in characterizing progressive liver disease in Asian-Americans with CHB. The increased risk of MASLD seen in our cohort may be due to the impact of acculturation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical Characteristics of Metabolic Dysfunction Steatotic Liver Disease in Asian-American Patients with Chronic Hepatitis B

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月16日

查看全文
  • Michel Mendler,
  • Edward Mena,
  • Michelle Gunawan,
  • Micaela Wong,
  • Brian Xu,
  • Tse-Ling Fong

摘要

The aim of this project was to determine the prevalence of fatty liver among Asian-American patients with chronic hepatitis B in a real-world setting, and to characterize the demographic, body composition and clinical features of these patients. This was a retrospective cross-sectional study of 115 Asian-American CHB patients followed at two clinical liver disease community programs in Southern California. Patients underwent standardized interviews, physical exams, body composition analysis (InBody® scan), laboratory studies, and assessment of liver stiffness and fat by FibroScan®. The median BMI of the cohort was 24.4 kg/m2, CAP was 250 dB/m, and liver stiffness was 5.0 kPa. Patients whose BMI were > 23 kg/m2 showed a significant increase in hepatic steatosis, percent body fat, years lived in the US, prevalence and number of metabolic syndrome components (obesity, hypertension, type 2 diabetes mellitus). Asians who immigrate to the US at a younger age have an increased risk of elevated BMI and consequent risk of MASLD. Body composition and liver disease progression differences across BMI in our cohort support the need for population-specific anthropometric parameters and underscores a BMI of 23 kg/m2 as an important cutoff point in characterizing progressive liver disease in Asian-Americans with CHB. The increased risk of MASLD seen in our cohort may be due to the impact of acculturation.